Ethic Inc. purchased a new position in Medical Properties Trust, Inc. (NYSE:MPW – Get Rating) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 15,502 shares of the real estate investment trust’s stock, valued at approximately $184,000.
A number of other hedge funds also recently modified their holdings of the stock. Janney Montgomery Scott LLC boosted its stake in Medical Properties Trust by 8.9% in the third quarter. Janney Montgomery Scott LLC now owns 471,278 shares of the real estate investment trust’s stock valued at $5,589,000 after buying an additional 38,408 shares in the last quarter. Mutual Advisors LLC boosted its stake in Medical Properties Trust by 13.0% in the second quarter. Mutual Advisors LLC now owns 83,430 shares of the real estate investment trust’s stock valued at $1,274,000 after buying an additional 9,630 shares in the last quarter. Pallas Capital Advisors LLC boosted its stake in Medical Properties Trust by 8.8% in the third quarter. Pallas Capital Advisors LLC now owns 129,099 shares of the real estate investment trust’s stock valued at $1,433,000 after buying an additional 10,463 shares in the last quarter. SG Americas Securities LLC boosted its stake in Medical Properties Trust by 50.9% in the third quarter. SG Americas Securities LLC now owns 82,469 shares of the real estate investment trust’s stock valued at $978,000 after buying an additional 27,815 shares in the last quarter. Finally, Capital Investment Advisors LLC boosted its stake in Medical Properties Trust by 13.3% in the third quarter. Capital Investment Advisors LLC now owns 459,458 shares of the real estate investment trust’s stock valued at $5,449,000 after buying an additional 54,102 shares in the last quarter. Institutional investors own 80.31% of the company’s stock.
Analyst Ratings Changes
A number of brokerages have recently commented on MPW. Bank of America raised Medical Properties Trust from a “neutral” rating to a “buy” rating and lifted their price target for the company from $13.00 to $16.00 in a research note on Monday, November 14th. They noted that the move was a valuation call. JPMorgan Chase & Co. cut their price target on Medical Properties Trust from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Friday, March 3rd. Mizuho cut their price target on Medical Properties Trust from $20.00 to $18.00 in a research note on Friday, December 2nd. Credit Suisse Group reissued a “neutral” rating and set a $11.00 price target on shares of Medical Properties Trust in a research note on Tuesday. Finally, Raymond James cut their price target on Medical Properties Trust from $18.00 to $16.00 and set a “strong-buy” rating on the stock in a research note on Thursday, March 2nd. Six investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.36.
Medical Properties Trust Price Performance
Medical Properties Trust Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 13th. Shareholders of record on Thursday, March 16th will be issued a $0.29 dividend. The ex-dividend date of this dividend is Wednesday, March 15th. This represents a $1.16 dividend on an annualized basis and a yield of 12.11%. Medical Properties Trust’s payout ratio is currently 77.33%.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust, engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities.
Featured Stories
- Get a free copy of the StockNews.com research report on Medical Properties Trust (MPW)
- Fossil Group: Should You Bet On Consumer Discretionary In 2023?
- BJ’s Wholesale Club Stock Moves Higher After Strong Results
- Monthly Realty Income is About to Get Bigger
- 3 Large Cap Dividend Challengers for Millennial Investors
- Sea Ltd Is On The Verge Of A 100% Rally, Should You Buy?
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.